Dose-escalated radiation vs. conventionally fractionated radiation for localized PC

2 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In this latest episode of the VJOncoAlert Journal Club, Comron Hassanzadeh, MD, MPH, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses long-term results of hypofractionated, dose-escalated radiation versus conventionally fractionated radiation for patients with localized prostate cancer. While earlier results indicated a benefit in treatment failure for hypofractionated radiation, this advantage is no longer statistically significant at the 13-year mark, though a trend remains.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Category
Oncology
Be the first to comment

Up Next